TFF Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference
FORT WORTH, Texas, May 23, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that CEO Harlan Weisman, M.D. will be presenting a corporate overview at the 2023 Jefferies Healthcare Conference being held in-person in New York, NY on June 7-9, 2023. Company management will also be participating in one-on-one meetings on Friday June 9th at the conference.
Related news for (TFFP)
- TFF Pharmaceuticals Announces It Will Wind Down Operations
- tff pharmaceuticals’ technology generates superior inhalational dry powder formulations for pulmonary drug delivery
- tff pharmaceuticals announces positive preclinical data from bivalent universal influenza vaccine candidates manufactured by tff following intranasal immunization
- tff pharmaceuticals to present at the h.c. wainwright 26th annual global investment conference
- TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference